ATC code L
|
WikiDoc Resources for ATC code L |
|
Articles |
|---|
|
Most recent articles on ATC code L |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on ATC code L at Clinical Trials.gov Clinical Trials on ATC code L at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on ATC code L
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on ATC code L Discussion groups on ATC code L Patient Handouts on ATC code L Directions to Hospitals Treating ATC code L Risk calculators and risk factors for ATC code L
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for ATC code L |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
A section of the Anatomical Therapeutic Chemical Classification System.
L Antineoplastic and immunomodulating agents
gl:Código ATC L hu:ATC L – Daganatellenes szerek és immunmodulátorok th:ATC รหัส L